Author： Pae Chi-Un Lee Soo-Jung Han Changsu Patkar Ashwin A Masand Prakash S
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.5, 2013-05, pp. : 565-572
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rifaximin for the treatment of irritable bowel syndrome
By Cremonini Filippo Lembo Anthony
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. :
Access to resources
Recommend
Treatment Options for Irritable Bowel Syndrome Set to Increase
Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 1, 2004-05 ,pp. :